Replies to post #651987 on NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

I actually think by being allowed to demand a jury trial, these companies are unwittingly setting themselves up to be strong armed by the DOJ — which is needed, because the SEC just hands out wrist slaps.

[beartrap12]

Captain, unfortunately, most Americans are oblivious to how much of their hard earned money is stolen from them in the stock market, the real estate market, and elsewhere. I also invested in real estate, then the rich brought on the Great Recession in 2008 that hit every area of middle class wealth. Yes, the rich lost money...on paper...but benefited from collecting up stock and real estate when it went cheap.
NWBO went through this too. They stopped the trial in 2009 because of the Great Recession created lack of financing, and lost two years. Many small companies like NWBO didn't survive.

[Know-Fear]

I hear what you’re saying, and tend to agree with the sentiment considering the current conditions for startups. But, private equities can be a double edge sword. People complain about lack of transparency now… Good article from the Atlantic pasted below. We didn’t know a lot of the details of the Toucan/Cognate transaction. But with the CRL announcement we saw several private equity firms were behind Cognate deal at that time, one of which I’m invested in one of their funds. I read their conference call transcripts and they can be word salad of vagueness. But, I don’t think investors complain because they’re earning a 10+ percent dividend and that’s what they want. So in essence, they buy their silence with the payout. The firms behind Cognate at the time of the CRL buyout of nearly $1 billion likely made a handsome profit. Which enables them to keep their investors happy….. but they might be a little thin on the details on how they achieve that end.

https://www.theatlantic.com/ideas/archive/2023/10/private-equity-publicly-traded-companies/675788/#[/tag]